Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J Mol Cell Cardiol. 2012 May 12;53(2):217–222. doi: 10.1016/j.yjmcc.2012.05.002

Table 2. Weights and weight ratios.

BL10 Mdx AAV treated
mdx
Sample Size (N) 8 12 8
Age (m) 23.98 ± 0.68 23.97 ± 0.15 23.83 ± 0.17
BW (g) 29.79 ± 1.47 a 19.17 ± 0.90 20.30 ± 0.51
TW (mg) 35.70 ± 2.14 28.60 ± 2.19 32.53 ± 2.85
HW (mg) 124.69 ± 5.56 a 105.80 ± 2.80 109.64 ± 3.22
VW (mg) 117.03 ± 5.22 b 97.70 ± 3.16 103.91 ± 3.09
TW/BW (mg/g) 1.20 ± 0.06 c 1.49 ± 0.08 1.62 ± 0.17
HW/BW (mg/g) 4.23 ± 0.20 a 5.64 ± 0.28 5.42 ± 0.18
HW/TW (mg/g) 3.59 ± 0.28 3.91 ± 0.27 3.73 ± 0.62
VW/BW (mg/g) 3.97 ± 0.18 a 5.20 ± 0.27 5.14 ± 0.18
VW/TW (mg/g) 3.36 ± 0.24 3.70 ± 0.31 2.75 ± 0.83

BW: Body Weight.

HW: Heart Weight.

TW: Anterior Tibialis Muscle Weight.

VW: Ventricle Weight.

a

Significantly different from other two groups.

b

Significantly different from untreated mdx only.

c

Significantly different from AAV treated mdx only.